157 related articles for article (PubMed ID: 8597607)
1. Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Greinix HT; Keil F; Brugger SA; Reiter E; Linkesch W; Lechner K; Schneider B; Dieckmann KU; Fischer G; Schwarzinger I; Haas O; Hinterberger W; Mannhalter C; Geissler K; Hocker P; Jager U; Kalhs P
Ann Hematol; 1996 Feb; 72(2):53-9. PubMed ID: 8597607
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
Woolfrey AE; Gooley TA; Sievers EL; Milner LA; Andrews RG; Walters M; Hoffmeister P; Hansen JA; Anasetti C; Bryant E; Appelbaum FR; Sanders JE
Blood; 1998 Nov; 92(10):3546-56. PubMed ID: 9808546
[TBL] [Abstract][Full Text] [Related]
3. Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors.
Greinix HT; Reiter E; Keil F; Fischer G; Lechner K; Dieckmann K; Leitner G; Schulenburg A; Hoecker P; Haas OA; Knoebl P; Mannhalter C; Fonatsch C; Hinterberger W; Kalhs P
Bone Marrow Transplant; 1998 Apr; 21(7):673-8. PubMed ID: 9578306
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
Fagioli F; Bacigalupo A; Frassoni F; Van Lint MT; Occhini D; Gualandi F; Lamparelli T; Clavio M; Vitale V; Sogno G
Bone Marrow Transplant; 1994 Mar; 13(3):247-52. PubMed ID: 8199567
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
Dini G; Boni L; Abla O; Uderzo C; Polchi P; Locatelli F; Di Bartolomeo P; Arcese W; Iori AP; Rossetti F
Bone Marrow Transplant; 1994 Jun; 13(6):771-6. PubMed ID: 7920313
[TBL] [Abstract][Full Text] [Related]
6. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
[TBL] [Abstract][Full Text] [Related]
7. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
9. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
10. Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia.
Greinix HT; Loidolt H; Rabitsch W; Schulenburg A; Keil F; Mitterbauer M; Laczika K; Lechner K; Dieckmann K; Fischer G; Jäger U; Rosenmayr A; Knöbl P; Schwarzinger I; Höcker P; Mannhalter C; Hinterberger W; Haas OA; Fonatsch C; Kalhs P
Ann Hematol; 2000 Apr; 79(4):206-13. PubMed ID: 10834508
[TBL] [Abstract][Full Text] [Related]
11. Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM).
Jourdan E; Maraninchi D; Reiffers J; Gluckman E; Rio B; Jouet JP; Michallet M; Molina L; Archimbaud E; Harousseau JL; Ifrah N; Attal M; Guilhot F; Kuentz M; Guyotat D; Pico JL; Dauriac C; Legros M; Dreyfus F; Bordigoni P; Leblond V; Gratecos N; Varet B; Auzanneau C; Blaise D
Bone Marrow Transplant; 1997 May; 19(9):875-81. PubMed ID: 9156260
[TBL] [Abstract][Full Text] [Related]
12. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
Demirer T; Petersen FB; Bensinger WI; Appelbaum FR; Fefer A; Rowley S; Sanders J; Chauncey T; Storb R; Lilleby K; Buckner CD
Bone Marrow Transplant; 1996 Jul; 18(1):29-34. PubMed ID: 8831992
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
[TBL] [Abstract][Full Text] [Related]
14. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
[TBL] [Abstract][Full Text] [Related]
15. Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation.
Atkinson K; Downs K; Dodds A; Concannon A; Milliken S
Aust N Z J Med; 1996 Feb; 26(1):54-8. PubMed ID: 8775529
[TBL] [Abstract][Full Text] [Related]
16. The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
Bacigalupo A; Vitale V; Corvò R; Barra S; Lamparelli T; Gualandi F; Mordini N; Berisso G; Bregante S; Raiola AM; Van Lint MT; Frassoni F
Br J Haematol; 2000 Jan; 108(1):99-104. PubMed ID: 10651732
[TBL] [Abstract][Full Text] [Related]
17. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
[TBL] [Abstract][Full Text] [Related]
19. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
